• Canagliflozin: SGLT2 Inhibitor Workflows for Renal Research

  2026-05-09

  Canagliflozin, a potent SGLT2 inhibitor, is revolutionizing diabetes and kidney disease research by targeting renal glucose reabsorption and remodeling mitochondrial function. This article delivers actionable protocols, advanced troubleshooting, and data-driven insights for maximizing Canagliflozin’s effectiveness in metabolic and renal studies.

• GM 6001 (Galardin): Precision MMP Inhibition for ECM Researc

  2026-05-08

  GM 6001 (Galardin) enables rigorous modulation of matrix metalloproteinase activity in cellular, tissue, and animal models, driving reproducible outcomes in ECM and signaling studies. This guide delivers actionable workflows, advanced use-cases, and troubleshooting strategies for extracting maximum value from this broad spectrum inhibitor.

• PERK Loss Sensitizes Colorectal Cancer to Ferroptosis via SL

  2026-05-08

  This study identifies PERK as a negative regulator of ferroptosis in colorectal cancer, showing that loss of PERK downregulates SLC7A11 (system Xc⁻) and primes tumor cells for iron-dependent cell death. These findings highlight a mechanistic link between ER stress pathways and ferroptosis vulnerability, informing new strategies in targeting therapy-resistant cancers.

• Reactive Oxygen Species Assay Kit: Advancing Cancer Research

  2026-05-07

  Explore how the Reactive Oxygen Species Assay Kit enables superior, quantitative ROS measurement in live cells using the DCFH-DA fluorescent probe. This deep dive reveals critical assay selection factors and practical insights for oxidative stress studies beyond standard protocols.

• PKH26 Red Fluorescent Cell Linker Kit: Protocols & Practical

  2026-05-07

  The PKH26 Red Fluorescent Cell Linker Kit addresses the need for stable, minimally toxic labeling of cell membrane lipid regions, supporting both in vitro and in vivo cell tracing and proliferation detection. This kit should not be used for intracellular or non-membrane labeling applications, ensuring specificity for membrane-based studies.

• Trelagliptin Succinate Ameliorates Cognitive Deficits in Dia

  2026-05-06

  A recent study demonstrates that Trelagliptin succinate, a long-acting and selective DPP-4 inhibitor, significantly improves cognitive impairment in a rat model of diabetes mellitus. The findings highlight modulation of PI3K/Akt/GSK-3β and inflammatory pathways as key mechanisms, with implications for translational research into diabetes-associated neurodegeneration.

• Amyloid β-Peptide (1-42): Workflow Advances for Neurotoxicit

  2026-05-06

  Unlock reproducible and translational neuroscience research with Amyloid β-Peptide (1-42) (Aβ42) from APExBIO. This article distills evidence-based workflows, troubleshooting, and key innovations to maximize reliability in Alzheimer's disease modeling and ion channel studies.

• H 89 2HCl in cAMP/PKA Signaling: Protocols, Pitfalls, and In

  2026-05-05

  H 89 2HCl, a potent and selective protein kinase A inhibitor, empowers researchers to dissect cAMP-dependent pathways with unprecedented specificity. This article delivers field-tested workflows, data-driven troubleshooting, and actionable insights—bridging advanced kinase biology and translational neuroinflammation research.

• Anlotinib Hydrochloride in IADSRCT: Clinical Application and

  2026-05-05

  This article reviews the first reported clinical use of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in treating intra-abdominal desmoplastic small round cell tumor (IADSRCT). The case demonstrates the drug's potential for controlling metastatic progression in this rare malignancy, with implications for anti-angiogenic cancer therapy research.

• Nintedanib (BIBF 1120): Precision Angiokinase Inhibition in

  2026-05-04

  Explore the advanced role of Nintedanib (BIBF 1120) as a triple angiokinase inhibitor in cancer research. This article uniquely unpacks mechanistic insights and practical considerations for biomarker-driven applications, grounded in recent high-grade glioma findings.

• Reactive Oxygen Species Assay Kit: Precision ROS Detection i

  2026-05-04

  Unlock quantitative oxidative stress analysis in live cells with the APExBIO Reactive Oxygen Species Assay Kit. This guide delivers workflow upgrades, troubleshooting insights, and direct translation of advanced cancer research findings into actionable assay protocols.

• Starvation, ER-Ca2+-Calpain Axis, and Cell Fate in Bombyx mo

  2026-05-03

  This study reveals how prolonged starvation in Bombyx mori induces a switch from autophagy to apoptosis in fat body tissue via the ER-Ca2+-calpain signaling axis. By dissecting calcium dynamics and the role of IP3R inhibition, the research clarifies mechanisms of programmed cell death under nutritional stress and highlights 2-APB’s utility in pathway interrogation.

• Prestained Protein Marker: Triple Color Ladder for Reliable

  2026-05-02

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO offers unmatched visibility, Phosbind compatibility, and streamlined workflows for SDS-PAGE and Western blotting. Its tri-color format and ready-to-use formulation empower researchers to achieve reproducible molecular weight determination and robust protein transfer assessment, even in advanced fluorescent imaging scenarios.

• Sex-Biased Gene Expression in Neural Differentiation of hESC

  2026-05-01

  This study delivers the first comprehensive analysis of sex-biased gene expression during neural differentiation in multiple human embryonic stem cell (hESC) lines. It demonstrates that genetic sex differences, independent of hormonal effects, shape neuronal developmental trajectories, revealing key candidate genes and implications for neurodevelopmental research.

• Polymyxin B Sulfate: Advanced Workflows in Immunity & Infect

  2026-05-01

  Polymyxin B (sulfate) from APExBIO uniquely bridges bactericidal power with immunomodulatory finesse—empowering both infection control and advanced immune modeling. This article details optimized protocols, troubleshooting, and the latest translational insights for maximizing assay reproducibility in multidrug-resistant Gram-negative research.

15201 records 1/1014 page Next 12345 下5页 Last page